GlassScriptPhysician profile
Nathan K Itoga
NPI 1366880098
$20,761.68
in general payments reported to CMS, 2019-2025
22 companies · $4,224 in 2025
The $4,224 reported for 2025 was more than what 82% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,471 · 2020: $796 · 2021: $1,803 · 2022: $2,047 · 2023: $1,916 · 2024: $8,504 · 2025: $4,224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,641 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Travel and Lodging: $1,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,641.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Travel and Lodging | $1,003.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $9,781.67 | 2021-2025 | Indigo System, Ruby Coil, Penumbra System |
| Silk Road Medical, INC. | $1,855.32 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Abbott Laboratories | $1,819.03 | 2019-2025 | Esprit, Jeti, Jeti Peripheral Catheter |
| Shockwave Medical, INC | $1,526.65 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $1,295.66 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $1,266.43 | 2020-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Medtronic, INC. | $831.66 | 2021-2024 | In.Pact Av, In.Pact Admiral |
| Bard Peripheral Vascular, INC. | $564.41 | 2020-2021 | |
| Bolton Medical INC | $433.80 | 2023-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Janssen Pharmaceuticals, INC | $240.83 | 2022 | |
| Inspiremd LTD | $229.61 | 2025 | Cguard Prime Carotid Stent System |
| Philips North America LLC | $188.73 | 2022-2023 | |
| Biocomposites INC | $150.00 | 2024 | |
| Janssen Scientific Affairs, LLC | $146.94 | 2022 | |
| Dilon Technologies, INC. | $128.13 | 2023 | Hemoblast Bellows |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $105.56 | 2022 | |
| Heartflow, INC. | $90.76 | 2019 | |
| Lemaitre Vascular, INC. | $27.70 | 2024 | Artegraft Vascular Graft |
| Cook Medical LLC | $26.06 | 2020 | |
| Inari Medical, INC. | $18.41 | 2022 | |
| Becton, Dickinson and Company | $17.83 | 2023 | Crosser Iq |
| Smith+Nephew, INC. | $16.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Itoga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.